{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T15:58:24Z","timestamp":1769183904385,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ejphar.2011.11.030","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T08:03:14Z","timestamp":1323417794000},"page":"265-274","source":"Crossref","is-referenced-by-count":63,"title":["Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity"],"prefix":"10.1016","volume":"674","author":[{"given":"Puneet","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harikesh","family":"Kalonia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.11.030_bb0005","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jchemneu.2009.02.001","article-title":"Cannabinoid (CB1), GABAA and GABAB receptor subunit changes in the globus pallidus in Huntington's disease","volume":"37","author":"Allen","year":"2009","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0015","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0306-4522(97)00079-1","article-title":"Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease","volume":"81","author":"Araujo","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2011.11.030_bb0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1745-7254.2005.00072.x","article-title":"Novel role for gabapentin in neuroprotection of central nervous system in streptozotocine-induced diabetic rats","volume":"26","author":"Baydas","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0025","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0030","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","article-title":"Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease","volume":"73","author":"Berman","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0035","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s11064-008-9610-3","article-title":"Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases","volume":"33","author":"Boll","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00004850-200403000-00001","article-title":"Huntington's disease: present treatments and future therapeutic modalities","volume":"19","author":"Bonelli","year":"2004","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0361-9230(94)00242-S","article-title":"Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats","volume":"36","author":"Borlongan","year":"1995","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1385-299X(96)00037-2","article-title":"Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model","volume":"1","author":"Borlongan","year":"1997","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0891-0618(99)00029-0","article-title":"Chemical and anatomical changes in the striatum and substantia nigra following quinolinic acid lesions in the striatum of the rat: a detailed time course of the cellular and GABA (A) receptor changes","volume":"17","author":"Brickell","year":"1999","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1750-3639.1999.tb00216.x","article-title":"Oxidative stress in Huntington's disease","volume":"9","author":"Browne","year":"1999","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF02335845","article-title":"Effects of DA agonist in Huntington disease hyperkinesia","volume":"1","author":"Caraceni","year":"1980","journal-title":"Ital. J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0166-2236(90)90111-M","article-title":"Excitotoxic injury of the neostriatum: a model for Huntington's disease","volume":"13","author":"DiFiglia","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-4-47","article-title":"Does neuroinflammation fan the flame in neurodegenerative diseases?","volume":"4","author":"Frank-Cannon","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0080","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0021-9258(18)57021-6","article-title":"Determination of serum proteins by means of the Biuret reaction","volume":"177","author":"Gornall","year":"1949","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N) nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Ann. Biochem."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0090","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1073\/pnas.0708930105","article-title":"Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin","volume":"105","author":"Hendrich","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pbb.2010.04.018","article-title":"Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor- \u03b3 (PPAR-\u03b3) in Huntington's disease","volume":"96","author":"Kalonia","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejphar.2010.02.031","article-title":"Targeting oxidative stress attenuates malonic acid induced Huntington like behavioral and mitochondrial alterations in rats","volume":"634","author":"Kalonia","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7748\/ns2004.04.18.32.45.c3596","article-title":"Huntington's disease","volume":"21","author":"Kent","year":"2004","journal-title":"Nurs. Stand."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0110","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.brainresbull.2006.12.006","article-title":"Lamotrigine inhibition of rotenone- or 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death","volume":"71","author":"Kim","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1254\/jphs.08067SC","article-title":"Protective effect of gabapentin on N-methyl-d-aspartate-induced excitotoxicity in rat hippocampal CA1 neurons","volume":"109","author":"Kim","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0125","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0076-6879(67)10061-X","article-title":"Preparation of succinate dehydrogenase and reconstitution of succinate oxidase","volume":"10","author":"King","year":"1967","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0076-6879(67)10055-4","article-title":"Preparations and properties of soluble NADH dehydrogenases from cardiac muscle","volume":"10","author":"King","year":"1967","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-9861(78)90479-4","article-title":"Generation of superoxide radical during auto-oxidation of hydroxylamine and an assay of superoxide dismutase","volume":"186","author":"Kono","year":"1978","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0140","first-page":"159","article-title":"Gabapentin attenuates acute hypoxic stress-induced behavioral alterations and oxidative damage in mice: possible involvement of GABAergic mechanism","volume":"46","author":"Kumar","year":"2008","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pnpbp.2008.10.013","article-title":"Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain","volume":"33","author":"Kumar","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2011.11.030_bb0150","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1089\/jmf.2008.0028","article-title":"Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease","volume":"12","author":"Kumar","year":"2009","journal-title":"J. Med. Food"},{"key":"10.1016\/j.ejphar.2011.11.030_bb0170","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00008877-200609000-00014","article-title":"Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms","volume":"17","author":"Kumar","year":"2006","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1358\/mf.2007.29.1.1063492","article-title":"Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity","volume":"29","author":"Kumar","year":"2007","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0155","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/10286020902862194","article-title":"Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats","volume":"11","author":"Kumar","year":"2009","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0175","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/FBP.0b013e32833a5bf4","article-title":"Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington's disease","volume":"21","author":"Kumar","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1734-1140(10)70238-3","article-title":"Huntington's disease: pathogenesis to animal models","volume":"62","author":"Kumar","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0160","article-title":"Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study","author":"Kumar","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pneurobio.2004.02.002","article-title":"Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease","volume":"72","author":"Lee","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0306-4522(99)00410-8","article-title":"Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy","volume":"95","author":"Lee","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2011.11.030_bb0190","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1471-4159.1997.69020581.x","article-title":"Mechanisms of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolinium bromide (MTT) reduction","volume":"69","author":"Liu","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0195","series-title":"Methods of Enzymatic Analysis","first-page":"885","article-title":"Catalase","author":"Luck","year":"1971"},{"key":"10.1016\/j.ejphar.2011.11.030_bb0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tins.2004.11.002","article-title":"Physiological functions for brain NF-kappaB","volume":"28","author":"Meffert","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0205","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.brainresbull.2008.10.007","article-title":"The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task and protocol-dependent: influence of non-motor factors on locomotor function","volume":"78","author":"Pallier","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM197302152880703","article-title":"Huntington's chorea: deficiency of gamma-aminobutyric acid in brain","volume":"288","author":"Perry","year":"1973","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0215","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-4522(01)00297-4","article-title":"Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-d-aspartate responses in medium spiny striatal neurons","volume":"106","author":"Pisani","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2011.11.030_bb0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mcn.2003.09.013","article-title":"Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease","volume":"25","author":"Saulle","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0225","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0197-0186(95)00122-0","article-title":"Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity","volume":"29","author":"Schulz","year":"1996","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0230","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0304-3959(99)00283-3","article-title":"Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn","volume":"85","author":"Shimoyama","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2011.11.030_bb0235","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1083\/jcb.32.2.415","article-title":"An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study","volume":"32","author":"Sottocasa","year":"1967","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0240","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbadis.2009.09.013","article-title":"Abnormal mitochondrial dynamics and neurodegenerative diseases","volume":"1802","author":"Su","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2011.11.030_bb0245","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.pbb.2005.10.018","article-title":"Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype","volume":"82","author":"Tadros","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0250","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2741\/2713","article-title":"Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?","volume":"13","author":"Tansey","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0255","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0306-4522(01)00164-6","article-title":"Behavioural correlates of striatal glial fibrillary acidic protein in the 3-nitropropionic acid rat model: disturbed walking pattern and spatial orientation","volume":"105","author":"Teunissen","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2011.11.030_bb0260","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1203\/PDR.0b013e318174e70e","article-title":"Gabapentin neuroprotection and seizure suppression in immature mouse brain ischemia","volume":"64","author":"Traa","year":"2008","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0265","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/FOC.2008.25.11.E6","article-title":"Ultra-structure protection and attenuation of lipid peroxidation after blockade of presynaptic release of glutamate by lamotrigine in experimental spinal cord injury","volume":"25","author":"Tufan","year":"2008","journal-title":"Neurosurg. Focus."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0270","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.lfs.2006.12.013","article-title":"Effect of testosterone on oxidative stress and cell damage induced by 3-nitropropionic acid in striatum of ovariectomized rats","volume":"80","author":"Tunez","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0275","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/mds.21540","article-title":"Clinical correlates of mitochondrial function in Huntington's disease muscle","volume":"22","author":"Turner","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0280","first-page":"244","article-title":"Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production","volume":"29","author":"Villar\u00e1n","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejphar.2011.11.030_bb0285","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejphar.2011.11.030_bb0290","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","article-title":"Mechanism of lipid peroxide formation in animal","volume":"99","author":"Wills","year":"1966","journal-title":"Biochem. J."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991101497X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991101497X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T14:16:14Z","timestamp":1639923374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991101497X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":58,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S001429991101497X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.11.030","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}